Reduced nucleic ZHX2 involves in oncogenic activation of glypican 3 in human hepatocellular carcinoma.

MLA

Luan, Fang, et al. “Reduced Nucleic ZHX2 Involves in Oncogenic Activation of Glypican 3 in Human Hepatocellular Carcinoma.” International Journal of Biochemistry & Cell Biology, vol. 55, Oct. 2014, pp. 129–35. EBSCOhost, https://doi.org/10.1016/j.biocel.2014.08.021.

APA

Luan, F., Liu, P., Ma, H., Yue, X., Liu, J., Gao, L., Liang, X., & Ma, C. (2014). Reduced nucleic ZHX2 involves in oncogenic activation of glypican 3 in human hepatocellular carcinoma. International Journal of Biochemistry & Cell Biology, 55, 129–135. https://doi.org/10.1016/j.biocel.2014.08.021

Chicago

Luan, Fang, Peng Liu, Hongxin Ma, Xuetian Yue, Jun Liu, Lifen Gao, Xiaohong Liang, and Chunhong Ma. 2014. “Reduced Nucleic ZHX2 Involves in Oncogenic Activation of Glypican 3 in Human Hepatocellular Carcinoma.” International Journal of Biochemistry & Cell Biology 55 (October): 129–35. doi:10.1016/j.biocel.2014.08.021.